While you may not yet know the name, you are very likely to recognise the legacy. Epredia is the culmination of nearly a century of a singular focus on advancing technologies and products that enhance precision cancer diagnostics. The company is powered by many of the most respected names in the industry – Shandon, Richard-Allan Scientific, Microm, Menzel-Gläzer, and others. Together, these brands represent ground-breaking technologies, a remarkable commitment to quality, and a deep dedication to enabling customers to achieve diagnostic excellence.
Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands, Epredia offers a wide range of solutions that have and will continue to transform the anatomical pathology market. The company offers a complete portfolio of instruments and consumables for the histology and cytology workflows, as well as printing and archiving systems for complete traceability and security of precious patient specimens.
Epredia will be at Congress in September, which will provide an ideal opportunity to become re-acquainted with the team and the company’s products and services.